1915 related articles for article (PubMed ID: 27255828)
21. Metabolomic-based biomarker discovery for non-invasive lung cancer screening: A case study.
O'Shea K; Cameron SJ; Lewis KE; Lu C; Mur LA
Biochim Biophys Acta; 2016 Nov; 1860(11 Pt B):2682-7. PubMed ID: 27423423
[TBL] [Abstract][Full Text] [Related]
22. Untargeted mass spectrometry-based metabolomic profiling of pleural effusions: fatty acids as novel cancer biomarkers for malignant pleural effusions.
Lam CW; Law CY
J Proteome Res; 2014 Sep; 13(9):4040-6. PubMed ID: 25117182
[TBL] [Abstract][Full Text] [Related]
23. Plasma metabolite profiling and chemometric analyses of lung cancer along with three controls through gas chromatography-mass spectrometry.
Musharraf SG; Mazhar S; Choudhary MI; Rizi N; Atta-ur-Rahman
Sci Rep; 2015 Feb; 5():8607. PubMed ID: 25712604
[TBL] [Abstract][Full Text] [Related]
24. Metabolomic markers of altered nucleotide metabolism in early stage adenocarcinoma.
Wikoff WR; Grapov D; Fahrmann JF; DeFelice B; Rom WN; Pass HI; Kim K; Nguyen U; Taylor SL; Gandara DR; Kelly K; Fiehn O; Miyamoto S
Cancer Prev Res (Phila); 2015 May; 8(5):410-8. PubMed ID: 25657018
[TBL] [Abstract][Full Text] [Related]
25. Metabolomic Analysis Using Liquid Chromatography/Mass Spectrometry for Gastric Cancer.
Liang Q; Wang C; Li B
Appl Biochem Biotechnol; 2015 Aug; 176(8):2170-84. PubMed ID: 26088916
[TBL] [Abstract][Full Text] [Related]
26. Metabolomic profiling reveals potential biomarkers in esophageal cancer progression using liquid chromatography-mass spectrometry platform.
Zhang H; Wang L; Hou Z; Ma H; Mamtimin B; Hasim A; Sheyhidin I
Biochem Biophys Res Commun; 2017 Sep; 491(1):119-125. PubMed ID: 28711496
[TBL] [Abstract][Full Text] [Related]
27. Bronchoalveolar Lavage Proteomics in Patients with Suspected Lung Cancer.
Carvalho AS; Cuco CM; Lavareda C; Miguel F; Ventura M; Almeida S; Pinto P; de Abreu TT; Rodrigues LV; Seixas S; Bárbara C; Azkargorta M; Elortza F; Semedo J; Field JK; Mota L; Matthiesen R
Sci Rep; 2017 Feb; 7():42190. PubMed ID: 28169345
[TBL] [Abstract][Full Text] [Related]
28. [Screening of serum oxysterol biomarkers for colon cancer by liquid chromatography-tandem mass spectrometry].
Ma Z; Li Z; Wang H; Wang R; Han X
Se Pu; 2022 Jun; 40(6):541-546. PubMed ID: 35616199
[TBL] [Abstract][Full Text] [Related]
29. Metabolomics analysis of bronchoalveolar lavage fluid samples in horses with naturally-occurring asthma and experimentally-induced airway inflammation.
Albornoz A; Alarcon P; Morales N; Uberti B; Henriquez C; Manosalva C; Burgos RA; Moran G
Res Vet Sci; 2020 Dec; 133():276-282. PubMed ID: 33039879
[TBL] [Abstract][Full Text] [Related]
30. Investigation of altered urinary metabolomic profiles of invasive ductal carcinoma of breast using targeted and untargeted approaches.
More TH; Taware R; Taunk K; Chanukuppa V; Naik V; Mane A; Rapole S
Metabolomics; 2018 Aug; 14(8):107. PubMed ID: 30830381
[TBL] [Abstract][Full Text] [Related]
31. Specificity of metabolic colorectal cancer biomarkers in serum through effect size.
Di Giovanni N; Meuwis MA; Louis E; Focant JF
Metabolomics; 2020 Aug; 16(8):88. PubMed ID: 32789702
[TBL] [Abstract][Full Text] [Related]
32. Multi-platform metabolomics assays for human lung lavage fluids in an air pollution exposure study.
Surowiec I; Karimpour M; Gouveia-Figueira S; Wu J; Unosson J; Bosson JA; Blomberg A; Pourazar J; Sandström T; Behndig AF; Trygg J; Nording ML
Anal Bioanal Chem; 2016 Jul; 408(17):4751-64. PubMed ID: 27113461
[TBL] [Abstract][Full Text] [Related]
33. Exploratory investigation of plasma metabolomics in human lung adenocarcinoma.
Wen T; Gao L; Wen Z; Wu C; Tan CS; Toh WZ; Ong CN
Mol Biosyst; 2013 Sep; 9(9):2370-8. PubMed ID: 23857124
[TBL] [Abstract][Full Text] [Related]
34. Utility of VEGF and sVEGFR-1 in bronchoalveolar lavage fluid for differential diagnosis of primary lung cancer.
Cao C; Sun SF; Lv D; Chen ZB; Ding QL; Deng ZC
Asian Pac J Cancer Prev; 2013; 14(4):2443-6. PubMed ID: 23725155
[TBL] [Abstract][Full Text] [Related]
35. Vascular Endothelial Growth Factor-D (VEGF-D) is Elevated in Bronchoalveolar Lavage Fluid of Patients with Lung Squamous Carcinoma.
Lv D; Tan L; Zhang Q; Ma H; Zhang Y; Zhang Q; Yu Y; Chen Z; Ding Q; Deng Z
Clin Lab; 2019 Jan; 65(1):. PubMed ID: 30775896
[TBL] [Abstract][Full Text] [Related]
36. Study of the metabolomics characteristics of patients with metabolic syndrome based on liquid chromatography quadrupole time-of-flight mass spectrometry.
Wu N; Wang W; Yi M; Cheng S; Wang D
Ann Endocrinol (Paris); 2018 Feb; 79(1):37-44. PubMed ID: 29246383
[TBL] [Abstract][Full Text] [Related]
37. Serum metabolic profiling study of lung cancer using ultra high performance liquid chromatography/quadrupole time-of-flight mass spectrometry.
Li Y; Song X; Zhao X; Zou L; Xu G
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Sep; 966():147-53. PubMed ID: 24856296
[TBL] [Abstract][Full Text] [Related]
38. Metabolomic analysis identifies altered metabolic pathways in Multiple Sclerosis.
Poddighe S; Murgia F; Lorefice L; Liggi S; Cocco E; Marrosu MG; Atzori L
Int J Biochem Cell Biol; 2017 Dec; 93():148-155. PubMed ID: 28720279
[TBL] [Abstract][Full Text] [Related]
39. An integrative approach based on GC-qMS and NMR metabolomics data as a comprehensive strategy to search potential breast cancer biomarkers.
Silva CL; Perestrelo R; Capelinha F; Tomás H; Câmara JS
Metabolomics; 2021 Aug; 17(8):72. PubMed ID: 34389918
[TBL] [Abstract][Full Text] [Related]
40. Breast cancer detection using targeted plasma metabolomics.
Jasbi P; Wang D; Cheng SL; Fei Q; Cui JY; Liu L; Wei Y; Raftery D; Gu H
J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Jan; 1105():26-37. PubMed ID: 30562627
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]